Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 261.1967. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover how biocatalytic synthesis of chiral pseudonucleosides offers superior enantioselectivity, reduced waste, and cost-effective production for your antiviral and antitumor drug development.